Scientists discover potential new target in fight against 'superbug'

January 29, 2013, Biotechnology and Biological Sciences Research Council

University of Cambridge researchers have discovered how an antibiotic-resistant superbug exploits oxygen-limited conditions in the lungs of patients with severe respiratory disease to thrive.

It is hoped the discovery could lead to new ways to target the Pseudomonas aeruginosa bacterium, which is responsible for six per cent of healthcare associated infections in NHS patients and has a widespread resistance to many antibiotics.

Infection by P. aeruginosa is a major cause of death in patients with Cystic Fibrosis.

The research, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and published in Open Biology, shows that an infection pathway in P. aeruginosa is activated when the bug encounters low-oxygen conditions.

Lead investigator Dr Martin Welch, from the University of Cambridge Department of Biochemistry, said: "This is particularly important because the bug is strongly associated with infections in patients with severe respiratory disease; most famously patients with cystic fibrosis - many of whom eventually succumb to P. aeruginosa infections.

"Counter-intuitively, the of such is oxygen-limited, so this could trigger the pathway."

P. aeruginosa infection the lungs promotes an that destroys lung tissue.

When the bug encounters low oxygen conditions, a mechanism called the Type III Secretion System (T3SS) is triggered.

The T3SS resembles a molecular-scale 'hypodermic syringe' which is thought to inject toxins directly from the bacterium into the , where they subvert its function and lead to .

The team identified a metabolic 'switch' regulating T3SS activity, called the glyoxylate shunt, which is activated when oxygen is sparse.

When this 'switch' is turned on an enzyme called isocitrate lyase (ICL) is expressed, leading to activation of the T3SS. In the absence of ICL, the T3SS is not turned on in low-oxygen conditions.

Dr Welch added: "The mechanism by which ICL impacts on the T3SS involves a previously unrecognised regulatory pathway.

"Crucially we found that this regulatory pathway also affected the formation of antibiotic-resistant biofilms by P. aeruginosa. This is important because biofilm formation is known to play an important role in the pathology of cystic fibrosis-associated infections. Our study therefore opens up new potential avenues for the development of novel antibacterial therapeutic interventions."

Dr Janet Allen, Director of Research at the Cystic Fibrosis Trust said: "Many people with Cystic Fibrosis will develop aeruginosa during their lives and it can cause chronic infection, which reduces lung function and therefore life expectancy. The Cystic Fibrosis Trust welcomes this research from the University of Cambridge which helps us to understand more about why this bacterium thrives in the lungs of those with cystic fibrosis, and could in the future lead to more treatments."

Professor Douglas Kell, BBSRC Chief Executive, said: "By understanding the intriguing mechanisms used by this during infections, this research could make a profound difference to for those with and may one day help to save lives."

Explore further: Researchers discover new vaccine candidate for Pseudomonas aeruginosa

More information: "Type III secretion system expression in oxygen-limited Pseudomonas aeruginosa cultures is stimulated by isocitrate lyase activity" by Chung et al. Open Biology, 2013.

Related Stories

Researchers discover new vaccine candidate for Pseudomonas aeruginosa

July 6, 2012
Researchers at Brigham and Women's Hospital (BWH) have discovered a new vaccine candidate for the bacterium Pseudomonas aeruginosa taking advantage of a new mechanism of immunity.

Recommended for you

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

Scientists unleash power of genetic data to identify disease risk

January 16, 2018
Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.